Obesity and Cardiovascular Disease: A New Dawn-Reference-Cited by-同舟云学术

Obesity and Cardiovascular Disease: A New Dawn

Published:2024-05-21 Issue:21 Volume:149 Page:1621-1623
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Sattar Naveed¹^ORCID,Neeland Ian J.²^ORCID,McGuire Darren K.³^ORCID

Affiliation:

1. School of Cardiovascular and Metabolic Health, University of Glasgow, UK (N.S.).

2. Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, OH (I.J.N.).

3. University of Texas Southwestern Medical Center and Parkland Health, Dallas (D.K.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Treating chronic diseases without tackling excess adiposity promotes multimorbidity

2. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

3. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

4. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

5. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Connecting the Dots: FGF21 as a Potential Link between Obesity and Cardiovascular Health in Acute Coronary Syndrome Patients;Current Issues in Molecular Biology;2024-08-03